TBPH
Theravance Biopharma Inc
Price:  
8.21 
USD
Volume:  
225,991.00
Cayman Islands | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TBPH Stock Forecast & Price Target

TBPH Stock Price Forecast

The average stock forecast for Theravance Biopharma Inc (TBPH) in the next 12 months is 13.46 USD. This price target corresponds to an upside of 64.00%. The range of stock forecasts for TBPH is 9.09 - 22.05 USD. Based on the ratings of 11 analysts, the consensus recommendation for TBPH is BUY.
Target Low Average Median High
Price (USD) 9.09 13.46 11.22 22.05
Upside 10.72% 64.00% 36.66% 168.57%

Recommendation Trends

The latest consensus rating for TBPH is "BUY". This is the average recommendation of 11 analysts: 0 strong sell, 0 sell, 4 hold, 4 buy, 3 strong buy. In the previous period, 11 analysts also majorly recommmended "BUY" for TBPH.

TBPH Financial Stock Forecast

Revenue This Year
60.20M
4.83%
from 57.42M
Revenue Next Year
87.47M
45.31%
from 60.20M
EPS This Year
-1.03
-8.30%
from -1.13
EPS Next Year
0.06
-106.11%
from -1.03